Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIFEDIPINE Cause Maternal exposure timing unspecified? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Maternal exposure timing unspecified have been filed in association with NIFEDIPINE (Nifedipine). This represents 0.1% of all adverse event reports for NIFEDIPINE.

6
Reports of Maternal exposure timing unspecified with NIFEDIPINE
0.1%
of all NIFEDIPINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From NIFEDIPINE?

Of the 6 reports, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIFEDIPINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does NIFEDIPINE Cause?

Foetal exposure during pregnancy (927) Drug ineffective (883) Premature baby (791) Maternal exposure during pregnancy (704) Premature delivery (555) Exposure during pregnancy (524) Hypotension (505) Off label use (474) Drug hypersensitivity (459) Completed suicide (431)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which NIFEDIPINE Alternatives Have Lower Maternal exposure timing unspecified Risk?

NIFEDIPINE vs NILOTINIB NIFEDIPINE vs NIMESULIDE NIFEDIPINE vs NIMODIPINE NIFEDIPINE vs NINTEDANIB NIFEDIPINE vs NINTEDANIB ESYLATE

Related Pages

NIFEDIPINE Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified NIFEDIPINE Demographics